Jorge Padilla

Dr. Jorge Padilla is senior managing director and head of Compass Lexecon Europe. He is a research fellow at the Centro de Estudios Monetariosy Financieros (CEMFI, Madrid) and teaches competition economics at the Toulouse School of Economics (TSE).  He has given expert testimony before the competition authorities and courts of several EU member states, as well as in cases before the European Commission. Dr. Padilla has submitted written testimony to the European General Court, and the UK Competition Appeals Tribunal in cartel, merger control and abuse of dominance cases. He has also given expert testimony in various civil litigation (damages), international arbitration cases, and competition cases in non-EU jurisdictions.

Dr. Padilla has written numerous papers on competition policy, industrial organization and finance in the Antitrust Bulletin, the Antitrust Law Journal, the Economic Journal, the Energy Journal, the European Competition Journal, the European Competition Law Review, the Fordham International Law Journal, Industrial and Corporate Change, the International Journal of Industrial Organization, the Journal of Competition Law and Economics, the Journal of Economics and Management Strategy, the Journal of Industrial Economics, the Journal of Economic Theory, the RAND Journal of Economics, the Review of Financial Studies, the University of Chicago Law Review, and World Competition.

Protecting Intellectual Property for National Security: A Transition Report for the New Administration

By Kirti Gupta, Andrei Iancu, Walter G. Copan, and Chris Borges This report was originally published on March 26th with CSIS. Download the full report here. Executive Summary The United States is undergoing a generational shift in how economic policy intersects with national security. Decades of globalization have exposed
Read More

The United States Cannot Afford Disarray as China Strengthens Its Biopharmaceutical Industry

By Sujai Shivakumar, Charles Wessner, and Julie Heng For years, China has played a leading role in manufacturing active pharmaceutical ingredients and generic drugs. While securing the supply chain for active pharmaceutical ingredients is increasingly recognized as a national security priority by policymakers, China’s growing role in biotechnological innovation has
Read More

Explainer: A Brief History of the International IP Regime

By Julie Heng, Arrizka Faida, and Chris Borges In a globalized economy, businesses rely on rules protecting intellectual property (IP) to safeguard their ideas and products against counterfeiting, piracy, and theft and to forge international partnerships. To this end, the United States and its partners have long invested in a system of multilateral treaties and international
Read More